Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-27

Clinical Trial Update: The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the efficacy and safety of L-Carnitine Injection for heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Carnitine Injection (L-Carnitine)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Heart Failure, | Phase 2, Phase 3 | Status: COMPLETED